Key Clinical Dosing Insights: Hypertension Management: Initial Dose: Typically starts at 2.5 mg once daily
Exenatide, MedlinePlus (2021) Dulaglutide, MedlinePlus (2023) Obesity in adolescents, The New England Journal of Medicine (2023) Nutrition and pubertal development, Indian Journal of Endocrinology and Metabolism (2014) GLP-1 receptor agonists and eating disorders, National Eating Disorder Association (n.d.) Facts about falls, Centers for Disease Control and Prevention (2024) Hypoglycemia in older people a less well recognized risk factor for frailty, Aging and Disease (2015) Ozempic, Novo Nordisk Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
doi: 10.2147/CPAA.S276085
Nauck and colleagues (1993) showed that GLP-1 infusion normalized elevated fasting glucose levels in T2D patients (via enhanced insulin secretion)
4.2 Open arena test The open arena test was used to observe the positive symptoms of schizophrenia in mice (10, 37, 38)
GLP-1s and Muscle Loss: What the Science Says Concerns about muscle loss have been specifically highlighted with GLP-1 medications, partly due to the significant and sometimes rapid weight loss they can induce
